Comparison of Bi 2 S 3 and Ta 2 O 5 as alternative materials to gold in nanoparticles used as agents to increase the dose in radiotherapy

Author:

Alejo-Martinez Harley,Sevilla-Moreno Andrés C.,Ondo-Mendéz Alejandro,Quintero Jorge H.,Páez Carlos J.

Abstract

Abstract Radiotherapy is an essential component in the treatment of all types of cancer. Radiotherapy uses ionizing radiation to destroy tumor tissue while reducing the damage to normal tissue as much as possible. In this work we study the effects of the spherical Bi 2 S 3 and Ta 2 O 5 nanoparticles (NPs) used as a radio-sensitization agent to increase local doses around the nanoparticle in a water medium. For low energy X-rays the dominant interaction is the photoelectric effect, which involves the absorption of a photon and the subsequent production of photoelectrons, characteristic X-rays and Auger electrons. Using a GEANT4 based simulation was determined the kinetic energy spectra of secondary electrons produced by the interaction of X-ray beam and Au, Bi 2 S 3 and Ta 2 O 5 NPs, after that was calculated the interaction processes, energy deposited, absorbed dose and the effective range distributions for the secondary electrons generated by the interaction of 100 million incident photons in the nanoparticles. The size of the nanoparticles was 20 nm and the energy distribution of the photons corresponds to the spectrum of a tube of x-rays with Tungsten anode and a peak voltage applied of 40 kV. This study demonstrates that Bi 2 S 3 and Ta 2 O 5 NPs are a viable alternative to Au NPs as a dose enhancing agent in radiotherapy.

Publisher

IOP Publishing

Subject

General Physics and Astronomy

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3